TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
GILD

Gilead Sciences Inc

Healthcare · Drug Manufacturers - General

150.90$ +0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Gilead Sciences Inc (GILD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 7,803 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GILD
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
7,500 7,320 6,505 7,141 6,512 5,949 5,088 5,648 5,596 5,795 5,281 5,685 5,604 5,879 5,548 5,143 6,577 7,421 6,423 6,217 7,421 7,244 6,590 6,260 7,042 7,389 6,352 6,599 7,050 7,114 6,686 6,953 7,545 7,569 6,667 7,081 7,769 7,924 6,960 7,803 30,456
1,129 1,075 957 1,126 1,032 1,256 1,001 1,196 1,086 1,570 957 1,000 1,035 1,683 969 1,064 1,141 1,398 1,361 1,390 1,223 2,627 1,424 1,442 1,395 1,396 1,401 1,442 1,565 2,090 1,552 1,544 1,574 1,581 1,540 1,501 1,569 1,624 1,445 1,579 6,217
6,371 6,245 5,548 6,015 5,480 4,693 4,087 4,452 4,510 4,225 4,324 4,685 4,569 4,196 4,579 4,079 5,436 6,023 5,062 4,827 6,198 4,617 5,166 4,818 5,647 5,993 4,951 5,157 5,485 5,024 5,134 5,409 5,971 5,988 5,127 5,580 6,200 6,300 5,515 6,224 24,239
1,141 1,208 931 864 789 1,150 937 1,192 939 1,950 1,057 995 1,030 1,899 1,004 1,299 1,158 1,578 1,055 1,092 1,101 2,027 3,878 1,102 1,149 1,152 1,447 1,407 1,457 1,408 1,520 1,351 1,395 1,641 1,379 1,491 1,346 1,584 1,372 1,764 6,066
831 992 850 897 879 1,252 997 980 948 1,131 1,030 1,095 1,052 1,204 1,076 1,239 1,106 935 1,055 1,351 1,190 915 1,083 6.7 1,213 1,242 6.7 1,849 1,315 754 632 572 442 992 505 501 528 652 553 1,921 3,654
1,972 2,200 1,781 1,761 1,668 2,402 1,934 2,172 1,887 3,081 2,087 2,255 6,042 3,103 2,177 7,062 3,435 3,372 2,172 2,581 2,356 3,677 4,969 2,789 2,810 3,726 3,246 3,492 2,862 3,412 9,456 2,765 5,083 3,536 2,890 3,106 2,873 3,312 2,929 16,618 25,732
4,399 4,045 3,767 4,254 3,812 2,291 2,153 2,280 2,623 1,144 2,237 2,430 -1,473 1,093 2,402 -2,983 2,001 2,651 2,890 2,246 3,842 940 197 2,029 2,837 2,267 1,705 1,665 2,623 1,612 -4,322 2,644 888 2,452 2,237 2,474 3,327 2,988 2,692 -10,394 -1,387
242 265 261 269 291 297 290 266 264 257 254 248 250 243 241 240 236 267 257 256 250 238 238 242 229 226 230 230 232 252 254 237 238 249 260 254 256 255 240 247 998
4,276 3,920 3,617 4,115 3,671 2,126 2,033 2,086 2,664 1,016 2,350 2,410 -1,501 1,901 2,003 -2,973 825 1,814 2,264 1,817 3,438 759 -152 1,503 2,432 2,031 1,300 1,588 2,318 1,653 -4,486 2,053 956 2,167 1,649 2,429 3,641 2,078 2,580 -10,254 -1,955
951 821 918 1,046 959 5,962 494 267 565 1,013 382 535 -333 -788 465 373 472 270 542 300 852 383 -164 368 646 398 316 549 146 237 -315 438 -297 385 334 468 589 -105 559 242 1,285
3,330 3,108 2,702 3,073 2,718 -3,865 1,538 1,817 2,097 3.0 1,975 1,880 -1,165 2,696 1,551 -3,339 360 1,551 1,729 1,522 2,592 382 19 1,144 1,789 1,640 1,010 1,045 2,180 1,429 -4,170 1,614 1,253 1,783 1,315 1,960 3,052 2,183 2,021 -10,496 -3,240
4,817 4,477 4,172 4,682 4,259 2,820 2,680 2,708 3,286 1,631 2,963 3,006 -904 2,494 2,593 -2,384 1,416 2,508 2,994 2,592 4,211 1,532 611 2,270 3,186 2,785 2,170 2,499 3,234 2,593 -3,542 2,984 1,884 3,109 2,605 3,374 4,583 3,020 3,509 -10,007 1,105

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?